Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams.

Dokic I, Mairani A, Niklas M, Zimmermann F, Chaudhri N, Krunic D, Tessonnier T, Ferrari A, Parodi K, Jäkel O, Debus J, Haberer T, Abdollahi A.

Oncotarget. 2016 Aug 1. doi: 10.18632/oncotarget.10996. [Epub ahead of print]

2.

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.

Harrabi SB, Bougatf N, Mohr A, Haberer T, Herfarth K, Combs SE, Debus J, Adeberg S.

Strahlenther Onkol. 2016 Jun 30. [Epub ahead of print]

PMID:
27363701
3.

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.

Adeberg S, Harrabi SB, Bougatf N, Bernhardt D, Rieber J, Koerber SA, Syed M, Sprave T, Mohr A, Abdollahi A, Haberer T, Combs SE, Herfarth K, Debus J, Rieken S.

Strahlenther Onkol. 2016 Jun 22. [Epub ahead of print]

PMID:
27334276
4.

Biologically optimized helium ion plans: calculation approach and its in vitro validation.

Mairani A, Dokic I, Magro G, Tessonnier T, Kamp F, Carlson DJ, Ciocca M, Cerutti F, Sala PR, Ferrari A, Böhlen TT, Jäkel O, Parodi K, Debus J, Abdollahi A, Haberer T.

Phys Med Biol. 2016 Jun 7;61(11):4283-99. doi: 10.1088/0031-9155/61/11/4283. Epub 2016 May 20.

PMID:
27203864
5.

Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.

Habl G, Uhl M, Katayama S, Kessel KA, Hatiboglu G, Hadaschik B, Edler L, Tichy D, Ellerbrock M, Haberer T, Wolf MB, Schlemmer HP, Debus J, Herfarth K.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):435-43. doi: 10.1016/j.ijrobp.2016.02.025. Epub 2016 Feb 12.

PMID:
27084659
6.

S-phase-specific radiosensitization by gemcitabine for therapeutic carbon ion exposure in vitro.

Harrabi SB, Adeberg S, Winter M, Haberer T, Debus J, Weber KJ.

J Radiat Res. 2016 Mar;57(2):110-4. doi: 10.1093/jrr/rrv097. Epub 2016 Jan 7.

7.

Data-driven RBE parameterization for helium ion beams.

Mairani A, Magro G, Dokic I, Valle SM, Tessonnier T, Galm R, Ciocca M, Parodi K, Ferrari A, Jäkel O, Haberer T, Pedroni P, Böhlen TT.

Phys Med Biol. 2016 Jan 21;61(2):888-905. doi: 10.1088/0031-9155/61/2/888. Epub 2016 Jan 7.

PMID:
26740518
8.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.

Jensen AD, Nikoghosyan AV, Lossner K, Haberer T, Jäkel O, Münter MW, Debus J.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):37-46. doi: 10.1016/j.ijrobp.2015.05.013. Epub 2015 May 19.

PMID:
26279022
9.

High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Welzel T, Uhl M, Federspil PA, Freier K, Krauss J, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.

Radiother Oncol. 2016 Feb;118(2):272-80. doi: 10.1016/j.radonc.2015.05.010. Epub 2015 Jul 8.

PMID:
26164774
10.

Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.

Jensen AD, Nikoghosyan AV, Poulakis M, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.

Cancer. 2015 Sep 1;121(17):3001-9. doi: 10.1002/cncr.29443. Epub 2015 Jun 4.

PMID:
26043145
11.

Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.

Rucinski A, Brons S, Richter D, Habl G, Debus J, Bert C, Haberer T, Jäkel O.

Radiat Oncol. 2015 Feb 27;10:56. doi: 10.1186/s13014-015-0348-1.

12.

Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma.

Nischwitz SP, Bauer J, Welzel T, Rief H, Jäkel O, Haberer T, Frey K, Debus J, Parodi K, Combs SE, Rieken S.

Radiother Oncol. 2015 May;115(2):179-85. doi: 10.1016/j.radonc.2015.03.022. Epub 2015 Apr 2.

PMID:
25842968
13.

Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.

Uhl M, Welzel T, Jensen A, Ellerbrock M, Haberer T, Jäkel O, Herfarth K, Debus J.

Strahlenther Onkol. 2015 Jul;191(7):597-603. doi: 10.1007/s00066-015-0825-3. Epub 2015 Mar 4.

PMID:
25737378
14.

Treatment of arrhythmias by external charged particle beams: a Langendorff feasibility study.

Prall M, Lehmann HI, Prokesch H, Richter D, Graeff C, Kaderka R, Sonnenberg K, Hauswald H, Weymann A, Bauer J, Constantinescu A, Haberer T, Debus J, Szabó G, Korkmaz S, Durante M, Packer DL, Bert C.

Biomed Tech (Berl). 2015 Apr;60(2):147-56. doi: 10.1515/bmt-2014-0101.

PMID:
25719279
15.

Atrioventricular node ablation in Langendorff-perfused porcine hearts using carbon ion particle therapy: methods and an in vivo feasibility investigation for catheter-free ablation of cardiac arrhythmias.

Lehmann HI, Richter D, Prokesch H, Graeff C, Prall M, Simoniello P, Fournier C, Bauer J, Kaderka R, Weymann A, Szabó G, Sonnenberg K, Constantinescu AM, Johnson SB, Misiri J, Takami M, Miller RC, Herman MG, Asirvatham SJ, Brons S, Jäkel O, Haberer T, Debus J, Durante M, Bert C, Packer DL.

Circ Arrhythm Electrophysiol. 2015 Apr;8(2):429-38. doi: 10.1161/CIRCEP.114.002436. Epub 2015 Jan 21.

16.

The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines.

Habermehl D, Ilicic K, Dehne S, Rieken S, Orschiedt L, Brons S, Haberer T, Weber KJ, Debus J, Combs SE.

PLoS One. 2014 Dec 2;9(12):e113591. doi: 10.1371/journal.pone.0113591. eCollection 2014. Erratum in: PLoS One. 2015;10(2):e0117960.

17.

In response to the comments to the paper 'Modelling of cell killing due to sparsely ionizing radiation in normoxic and hypoxic conditions and an extension to high LET radiation' by T. Friedrich et al.

Mairani A, Böhlen TT, Dokic I, Cabal G, Brons S, Haberer T.

Int J Radiat Biol. 2015 Jan;91(1):129-31. doi: 10.3109/09553002.2015.985115. No abstract available.

PMID:
25380346
18.

Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results.

Uhl M, Mattke M, Welzel T, Roeder F, Oelmann J, Habl G, Jensen A, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Debus J.

Cancer. 2014 Nov 1;120(21):3410-7. doi: 10.1002/cncr.28877. Epub 2014 Jun 19.

19.

Improvements for extending the time between maintenance periods for the Heidelberg ion beam therapy center (HIT) ion sources.

Winkelmann T, Cee R, Haberer T, Naas B, Peters A, Schreiner J.

Rev Sci Instrum. 2014 Feb;85(2):02A951. doi: 10.1063/1.4860651.

PMID:
24593530
20.

High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.

Uhl M, Mattke M, Welzel T, Oelmann J, Habl G, Jensen AD, Ellerbrock M, Haberer T, Herfarth KK, Debus J.

Cancer. 2014 May 15;120(10):1579-85. doi: 10.1002/cncr.28606. Epub 2014 Feb 5.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk